Abstract
In winter of 2019-2021 SARS-CoV-2 became pandemic (CoVID-19 or P). During P, treating patients with chronic disease burden, i.e., cancer (O), with multiple myeloma (MM) oncologics and achieving high medication adherence was reported to be challenging, e.g., delayed/missed provider visits, prescriptions, lab tests, and P-related financial difficulties and feelings of depression or anxiety. There are two Objectives: that characterize how the P may be associated with changes in: 1. adherence to specialty pharmacy MM medications (O-SP-D) and 2.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
